Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Routine Diagnostic Test for Lemierre Syndrome Is Required

By LabMedica International staff writers
Posted on 09 Dec 2009
Physicians when diagnosing sore throat, or pharyngitis, in adolescents and young adults must consider the newly identified, potentially dangerous Fusobacterium necrophorum as the source of infection. More...
The bacterium can cause Lemierre syndrome, a potentially dangerous condition.

Symptoms of Lemierre syndrome include unilateral neck swelling, rigors, night sweats, or high fevers. Currently there is no routine test for F. necrophorum pharyngitis, and a CT scan is required to detect Lemierre syndrome. In the event that the disease is diagnosed, aggressive treatment with antibiotics such as a combination of penicillin and metronidazole or with clindamycin alone is appropriate.

Lemierre syndrome mostly affects adolescents and young adults and rarely is seen in preadolescents. It begins with a sore throat, followed by an infected jugular vein after four to five days. Abscesses in other parts of the body may occur. Approximately 5 percent of people who get Lemierre syndrome die.

Physicians are trained to suspect group A streptococcal bacteria as the primary cause of pharyngitis. But according to findings by investigators at the University of Alabama at Birmingham (UAB; USA), and published on December 1, 2009 in the Annals of Internal Medicine, sore throat in young adults and adolescents that worsens or is strep-negative, could be due to F. necrophorum. Although group A strep. is associated with rheumatic fever, the incidence and rate of Lemierre syndrome following exposure to F. necrophorum is much higher and associated with greater morbidity and mortality.

Robert Centor, M.D., professor of internal medicine, associate dean of medicine at UAB and the paper's lead author, said, "F. necrophorum, which only has been recognized as a potential cause of pharyngitis in adolescents and young adults in the past five years, may cause up to 10 percent of sore throat in those 15-24 years of age. More important, F. necrophorum is associated with a rare but life-threatening complication called Lemierre syndrome."

Prof. Centor added that he hopes this analysis will lead to better diagnostic tests for the presence of F. necrophorum.

Related Links:

University of Alabama at Birmingham



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.